Medical News Today: Oncology News

Teenagers with cancer often report feelings of isolation, bitterness, confusion, pain, and fear as they struggle through a life-threatening disease before their lives have taken full shape. Despite these very real challenges, many teens with cancer find their needs unmet...

Having diabetes or being obese after age 60 significantly increases the risk for developing breast cancer, a Swedish study has revealed. Data also showed that high blood lipids were less common in patients when diagnosed with breast cancer, while low blood lipids were associated with an increased risk...

The American Society of Clinical Oncology (ASCO) today released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest impact on patient care this year...

Recreational use of Ecstasy - the illegal "rave" drug that produces feelings of euphoria and emotional warmth - is associated with chronic changes in the human brain, Vanderbilt University investigators have discovered...

Researchers at Karolinska Institutet have demonstrated that a growth hormone, PDGF-BB, and the blood protein EPO are involved in the development of cancer tumours and that they combine to help the tumours proliferate in the body. These new preclinical findings offer new potential for inhibiting tumour growth and bypassing problems of resistance that exist with many drugs in current use...

Researchers have demonstrated a new imaging tool for tracking structures called carbon nanotubes in living cells and the bloodstream, which could aid efforts to perfect their use in biomedical research and clinical medicine. The structures have potential applications in drug delivery to treat diseases and imaging for cancer research...

An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab...

Microbial causing infectious diseases is associated with more than 30% off all cancers. In the recent years several prophylactic vaccines that have been developed proved to be an important essence impacting the incidence of liver cancer and cervical cancer...

Effective treatments for a wide verity of cancers are still very slow and costly to develop with many prospective drugs ending up in being scraped. With the current economic climate businesses of all sizes are looking for new ways to develop drugs in a smarter manner with reduced production time and improved methods of predicting futility to prevent wasted time and money...

Arterial calcification and coronary heart disease, neurodegenerative diseases such as Parkinson's and Alzheimer's, cancer and even the aging process itself are suspected to be partially caused or accelerated by oxidative stress. Oxidative stress arises in tissues when there is an excess of what are called reactive oxygen species (ROS)...

The American Society of Clinical Oncology (ASCO) released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest impact on patient care this year...

BGI, the world's largest genomics organization, announced that a study on frequent mutation of genes encoding ubiquitin-mediated proteolysis pathway (UMPP) components in clear cell renal cell carcinoma (ccRCC) is published online in Nature Genetics. In addition to BGI, co-leaders of the study included Peking University Shenzhen Hospital, Shenzhen Second People's Hospital, among others...

A study by researchers Raul Mendez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona) and Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) describes a new reprogramming mechanism for the expression of genes responsible for turning a healthy cell into a tumor cell...

A drug discovery team at Genentech, Inc., has uncovered a chink in the molecular armor of Ras, the most commonly occurring oncogene, which is a gene that when mutated has the potential of causing cancer in humans...

Two studies available in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, have uncovered limitations in screening for primary liver cancer, also known as hepatocellular carcinoma (HCC)...

Just 24 hours after Lisa Rek sang at her niece's wedding, her husband Brad was driving her to a local hospital. "The pain got worse. When we got to the emergency room, I said to Brad 'something is just not right,'" Rek remembers...

CARDIOLOGY: Unraveling the adverse effects of a blood pressure medication Drugs that block L-type Ca2+ channels (LTCCs) are widely used to treat high blood pressure and angina, chest pain caused by restriction of the blood flow to the heart. However, these drugs can have adverse effects in patients with heart failure...

One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients...

Cancer researchers are developing a catalog of potential targets for novel treatments while they continue to identify genetic mutations powering different cancer subtypes. Recently, the University of Michigan Comprehensive Cancer Center and Michigan Center for Translational Pathology (MCTP) completed a pilot investigation...

The Prostate Cancer Foundation's Young Investigator awards encourage the most innovative minds in cancer research to investigate prostate cancer. The Foundation awards selected researchers with $225,000 over three years to help support their research on prostate cancer treatment and patients...